A simple, rapid, and sensitive reversed-phase HPLC method was developed and validated for determination of metronidazole and tinidazole in human plasma samples under identical chromatographic conditions. This method involves liquid-liquid extraction using chloroform: isopropylalcohol (95:5). Chromatographic separation was performed using a μ-bondapack C18 (250 mm × 4.6 mm) column. The mobile phase consisted of potassium dihydrogen phosphate solution (0.005 M)/acetonitrile (80/20 v/v). The final pH of the mobile phase was adjusted to 4 ± 0.1 with orthophosphoric acid. The calibration curves were linear over the concentration range 0.1–15 μg/mL for metronidazole and tinidazole with the detection limit of 30 ng/mL. Within- and between-day precision and accuracy did not exceed 9.83% and 10.48%, respectively. Metronidazole and tinidazole were found to be stable in plasma samples with no evidence of degradation during 3 freeze-thaw cycles and 3 months storage in −70 °C. The current validated bio-analytical method was finally applied in bioequivalence studies of two different metronidazole and tinidazole products according to a standard two-way cross-over design with a two-week washout period. No statistically significant difference was observed between the logarithmically transformed AUC0-∞ and Cmax values. Therefore, generic products were considered bioequivalent with those of standards which could be used interchangeably.
[1]. JEF. Reynolds. Martindale, The Extra Pharmacopoeia, The Royal Pharmaceutical Society, Great Britain, London; 2006, pp. 594–596.
[2]. E.D. Ralf , Clin. Pharm., 8 (1983).
[3]. J.G. Hardman L.E. Limbird A.G. Gilman 2001 Goodman & Gilman's. The pharmacological basis of therapeutics 10th ed. Mc Graw-Hill NewYork.
[4]. C. Gjerloff , E. Arnold, Acta. Pharmacol. Toxicol, 51 (1982).
[5]. B. Horatio , T. Thien, Clin. Ther., 27 (2005).
[6]. A.O. Adegoke , O.K.E. Umoh, J.O. Soyinka. J. Chem. Soc., 7 (2010).
[7]. E. Vega , N. Sola. J. Pharm. Biomed. Anal., 25 (2001).
[8]. British Pharmacopoeia, Her Majestry Stationery Office, London, 2002, pp. 98, 1814 and 1815.
[9]. A. Ozkan , Y. Ozkan, Z. Senturk, J. Pharm. Biomed. Anal., 17 (1998).
[10]. W. Jin , W. Li, Q. Xu, Q. Dong, Electrophoresis, 21 (2000).
[11]. M.J. Jessa , D.A. Barrett, P.N. Shaw, R.C. Spiller, J. Chromatogr. B, 677 (1996).
[12]. J. Emami , N. Ghassami, H. Hamishehkar, Daru, 14 (2006).
[13]. M.J. Galmier , A.M. Frasey, M. Bastide, E. Beyssac, J. Petit, J.M. Aiache, C. Lartigue-Mattei, J. Chromatogr. B, 720 (1998).
[14]. R.A. Gibson , L. Lattanzio, H. Mcgee, Clin. Chem., 30 (1984).
[15]. H.W. Sun , F.C. Wang, L.F. Aie, J.Chromatogr. B. 857 (2007).
[16]. T.J. Venkateswaran , J.T. Stewart, J. Chromatogr. B, 672 (1995).
[17]. K.B. Mustapha , M.T. Odunola, M. Garba, O. Obodozie. J. Biotech., 5 (2006).
[18]. Y-H. Tu , Y. Wang, L. Allen, Int. J. Pharmaceutic., 61 (1990).
[19]. M. Silva , S. Schramm, E. Kanoe Kono, V. Port A. C. Serra. J. Chromatogr. Sci., 47 (2009).
[20]. P. Chaikin , K.B. Alton, D.C. Sampson, W. Weintraub, J. Clin. Pharmaco., 22 (1982).
[21]. M. Bakshi , S. Singh, J. Pharmaceutic. Biomed. Anal., 34 (2004).
[22]. K. Phasa , A. Ali, S. Bana, and S. Humair, Int. J. Pharm. Pharmaceutic. SIC, 2 (2010).
[23]. K. Rajnarayana , M.R. Chaluvadi, V.R. Alapati, S.R. Mada, G. Jayasagar, D.R. Krishna, Pharmazie, 57 (2002).
[24]. I. Nilson-Ehle , B.O. Ursing, P. Nilson-Ehle, J. Antimicrob. Chemo., 19 (1981).
[25]. J Mattlla , T. Manntsto, R. Mantyla, S. Nykanen, Antimicrog. Agent. Chemother., 23 (1983).
[26]. J. Virtanen , H. Haataja, P.T Mannisto, J. Antimicrob. Agent. Chemother., 28 (1985).
[27]. H. Mattie , B A.C. Dijkmans, C. Gulpen, J. Antimicrob. Chemother., 1 (1982).
[28]. A.L Crowell , A Kolby, W.E Secor, Antimicrob. Agent. Chemother., 47 (2003).
[29]. L. Shargel S. W. Pong A.B.C. Yu 2005 Applied biopharmaceutics and pharmacokinetics 5th ed. MC Graw Hill New York 435–475.
[30]. A. Menelaou , A.A Somogyi, M.L Barclay, F. Bochner, J. Chromatogr. B, 27 (1999).